Sign in
MT

MICROCHIP TECHNOLOGY INC (MCHP)·Q3 2025 Earnings Summary

Executive Summary

  • Net sales were $1.026B, down 11.8% q/q and 41.9% y/y; revenue landed essentially on the updated December 2 guidance of ~$1.025B, but margins compressed materially on underutilization charges and elevated inventory .
  • Non-GAAP EPS of $0.20 missed updated guidance of $0.25; GAAP EPS of $(0.10) was below the Nov. 5 guidance range of $(0.04)–$0.03 as profitability was pressured by capacity/utilization costs and amortization of intangibles; inventories reached 266 days .
  • March-quarter (Q4 FY25) guidance: net sales $920M–$1.000B; non-GAAP GM 52%–54%; non-GAAP EPS $0.05–$0.15; capex ~$23M—management remained cautious on bookings and visibility but flagged a March 3 business update on a 9‑point plan and manufacturing footprint restructuring (Fab 2 closure) .
  • Capital returns continued: $244.6M dividend cash returned in December; dividend of $0.455 for March declared; management reiterated commitment to the dividend despite near-term FCF/interest timing, highlighting future inventory-driven cash liberation as a catalyst .

What Went Well and What Went Wrong

What Went Well

  • Revenue execution in-line with updated guidance; bookings for March running higher than December, though overall levels remain low .
  • Strategic actions initiated: resizing manufacturing (Fab 2 shutdown), distribution margin/pricing changes, focus on top 1,000 customers; CEO: “decisive steps we are taking to realign our business” .
  • Product momentum: COO cited strong traction in RISC‑V processors, connectivity, aerospace/industrial; expanded AI, networking and security capabilities positioning for recovery .

What Went Wrong

  • Profitability miss: non-GAAP EPS $0.20 vs guided $0.25; GAAP EPS loss exceeded guidance range; non-GAAP GM fell to 55.4% amid $42.7M capacity/utilization charges .
  • Inventory elevated: 266 days on balance sheet; direct customer inventories remained high; distribution sell-through exceeded sell-in by $118M, creating revenue/margin friction .
  • OpEx headwinds: operating expenses rose as employees returned to full pay late Nov/early Dec; OpEx expected higher again in March quarter, suppressing operating leverage near-term .

Financial Results

MetricQ3 FY24Q1 FY25Q2 FY25Q3 FY25
Revenue ($USD Billions)$1.766 $1.241 $1.164 $1.026
GAAP Diluted EPS ($)$0.77 $0.24 $0.14 $(0.10)
Non-GAAP Diluted EPS ($)$1.08 $0.53 $0.46 $0.20
GAAP Gross Margin (%)63.4% 59.4% 57.4% 54.7%
Non-GAAP Gross Margin (%)63.8% 59.9% 59.5% 55.4%
Non-GAAP Operating Margin (%)41.2% 31.5% 29.3% 20.5%
Sequential/YoY ChangeQ3 FY25 vs Q2 FY25Q3 FY25 vs Q3 FY24
Revenue change (%)−11.8% −41.9%
CommentaryCapacity/utilization charges and weak bookings pressured margins Post‑COVID inventory correction across customers/channels

Segment breakdown: Not disclosed in the company’s Q3 FY25 press release/8‑K and call materials .

KPIs

KPIQ3 FY24Q2 FY25Q3 FY25
Inventory Days (Company)—247 (prior quarter reference) 266
Distribution Inventory Days—40 (approx., prior quarter reference implied) 37
Cash from Operations ($M)$853.3 $43.6 $271.5
Free Cash Flow ($M)$793.8 $22.8 $253.4
Capital Expenditure ($M)$59.5 $20.8 $18.1
Adjusted EBITDA ($M)——$274.9
Net Debt / Adjusted EBITDA (x)——3.78

Notes: Q2 FY25 cash flow metrics per Sept quarter; distribution sell-through exceeded sell-in by $118M in Q3 FY25 .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Net Sales ($B)Q3 FY25 (Dec qtr)$1.025–$1.095B (Nov. 5) “Close to low end” ≈$1.025B (Dec. 2 update) Lowered (to low end)
Net Sales ($B)Q3 FY25 Actual—$1.026B In‑line with update
GAAP EPS ($)Q3 FY25$(0.04)–$0.03 (Nov. 5) —Actual below range: $(0.10)
Non-GAAP EPS ($)Q3 FY25$0.25–$0.35 (Nov. 5) $0.25 (Dec. 2 update) Actual miss: $0.20
Net Sales ($B)Q4 FY25 (Mar qtr)—$0.920–$1.000 New guidance
Non-GAAP Gross Margin (%)Q4 FY25—52.0–54.0 —
Non-GAAP OpEx (% sales)Q4 FY25—37.7–40.5 —
Non-GAAP Operating Margin (%)Q4 FY25—11.5–16.3 —
Non-GAAP EPS ($)Q4 FY25—$0.05–$0.15 —
Capex ($M)Q4 FY25 / FY25~$23 / ~$135 —Maintained
DividendQ3 FY25Declared $0.455 per share Paid Mar 7; record Feb 24 Maintained

Earnings Call Themes & Trends

TopicQ1 FY25 (Jun qtr)Q2 FY25 (Sep qtr)Q3 FY25 (Dec qtr)Trend
Inventory destocking & visibilityElevated inventory; design momentum intact; cautious outlook Inventory correction amid macro weakness; “green shoots” uneven; Europe weakness Inventory days 266; direct customer inventory high; bookings low but improving for March Destocking continues; early signs of improvement
Manufacturing footprint & utilizationCapacity investments to support growth; capex $35–$40M guidance Cost discipline; no major footprint changes disclosed Fab 2 closure plan; rotating time-off; underutilization charges; Q4 non-GAAP GM 52–54% Rightsizing footprint; margin recovery targeted
Distribution/channel strategyStandard approach; demand creation pipeline Normalized cancels; expedite requests higher Switching demand creation flags to fulfillment; lower fulfillment margins to drive new product push Realignment toward fresh design wins
PricingNot highlightedMacro/pricing pressures implied Near-term low to mid-single digit price reductions; long-term not necessarily annual decreases Normalization post COVID price hikes
AI/technology initiativesNeuronix AI Labs; data center portfolio expansion Data center adoption in AI‑accelerated servers; PCIe/CXL strength RISC‑V processors, Wi‑Fi, touch, automotive networking; space certifications; NVIDIA Holoscan integration Broadening portfolio positions for recovery
Capital returns & balance sheetBuybacks/dividends sustained Dividend increased; cash discipline Dividend commitment despite FCF timing; bond refinancings; net debt to EBITDA higher Maintain dividend; refinance risk addressed

Management Commentary

  • CEO: “Our December quarter performance reflects the need for the decisive steps we are taking to realign our business, as revenue declined to $1.026 billion and inventory levels reached 266 days…restructuring our manufacturing footprint, adjusting our channel strategy and intensifying our customer engagement” .
  • CFO: “Non-GAAP gross margins were 55.4%, including capacity and utilization charges of $42.7 million…Operating expenses increased…and will further increase in the first quarter due to [employees] coming off a cut” .
  • COO: “Our comprehensive technology platform is driving innovation…new RISC‑V processors and expanded connectivity solutions demonstrating strong momentum in industrial, automotive, and aerospace” .
  • CEO (outlook): “Everyone would like me to call the last quarter as a bottom…bookings remain low although…running at a higher rate…we expect net sales…between $920 million and $1 billion” .

Q&A Highlights

  • Inventory hotspots: Elevated across end markets; distribution inventory nearing normal, but direct customer inventory high due to PSP timing and preferential allocation during tight supply; distribution sell-through exceeded sell-in by $118M .
  • Gross margin trajectory: Guided non-GAAP GM ~53% despite low utilization; expects return to historical levels as utilization normalizes and OpEx is corrected; more details on Mar 3 .
  • Growth vs market: Strategy to outgrow via megatrends/design wins and inventory normalization; cautious on timing, but confident in long-term above‑market growth prospects .
  • Pricing normalization: Short-term low to mid-single digit reductions post COVID price increases; long-term not necessarily annual declines .
  • Capital structure: Refinancing risk on $1.2B Sept 2025 maturity addressed via line/commercial paper; next major tranche in 2028 .
  • Dividend commitment: Maintain dividend despite periodic shortfalls vs adjusted FCF due to semiannual bond interest timing; expect improvement as inventory frees cash .

Estimates Context

  • S&P Global consensus for Q3 FY25 revenue and EPS was unavailable in this session due to provider limits; therefore, comparisons to Street estimates cannot be provided. Management’s updated guidance (Dec. 2) implied revenue at the low end (~$1.025B); actual revenue was in-line, while non-GAAP EPS and GAAP EPS were below prior guidance ranges .
  • Where estimates may adjust: Given margin compression from utilization and higher OpEx, near-term EPS estimates likely shift lower; subsequent quarters could modestly recover as inventories/days and underutilization charges decline, subject to bookings improvement .

Key Takeaways for Investors

  • Execution: Revenue met updated guidance, but profitability missed; watch for margin recovery drivers (utilization normalization, OpEx control) and specifics in the Mar 3 update .
  • Inventory/cash catalyst: Elevated inventory (266 days) creates headwind now but a medium-term FCF tailwind as days normalize; distribution days improved to 37 and sell-through > sell-in aids channel normalization .
  • Footprint restructuring: Fab 2 closure and rotating time-off schedules should lower fixed-cost absorption over time; track timing and P&L impact in FY26 as FIFO inventory rolls .
  • Demand creation reboot: Changes to distributor incentives and flags aim to prioritize new product sockets; look for design-win momentum in RISC‑V, connectivity, automotive networking, FPGA/AI stacks .
  • Dividend discipline: Management intent to maintain dividend despite near-term FCF timing; balance sheet actions (bond issuance/retirements) reduce refinancing risk; monitor net debt/EBITDA as earnings recover .
  • Guidance watch: Q4 FY25 guide embeds cautious bookings; earnings leverage hinges on OpEx and utilization; monitor non-GAAP GM 52%–54% and OpEx %sales 37.7%–40.5% .
  • Trading implication: Near-term sentiment hinges on Mar 3 plan clarity and evidence of inventory/OpEx progress; a credible path to margin normalization and cash liberation could re-rate the stock despite cyclical revenue trough dynamics .